Originally posted by Neil1959
Hi guys,
Thanks
@YankieTank, Bas and others for your questions that have been posted on here or have come directly to my email.
I would like to help answer a few of these this morning and also address repetitive posts that continually get raised in the forum.
1) Was there an issue between Medcan and CGB over performance shares?
No... our relationship with Medcan is strong and they have been very willing to work with us to help CGB achieve its goals. To that end CGB and Medcan have now signed a Variation in Agreement. Please see post #37514175.
2) Are we deleting comments on FB posts?
Yes! We apply the same security protocols across our SM network as HC uses here. Shareholders will often contact us and report these comments. We remove or hide any comments that are defamatory, have profanity, troll or spam unnecessary content. We will try and address those comments where visitors are concerned or require clarification or we may redirect the poster to the company, if providing an answer on the page is either unsatisfactory or requires more depth in the response.
3) Why is the company releasing all these Supplementary prospectus'?
A prospectus is a formal legal document that is required by, and filed with ASIC that provides details about an investment offering for sale to the public. As an official and legal document, a company is required to notify ASIC in writing of any material changes, or variations in the agreement. If there is an alteration to the original prospectus the company must notify ASIC and detail the changes. These changes, updates, alterations, or clarifications are detailed in Supplementary Prospectuses. A time period for the process of the prospectus, Capital Raise can be up to 16 weeks. In the case of Cann Global, and due to the new deals being signed, changes in operations, new internal organisational changes (materially sensitive) and now the variation of agreement with Medcan (save share issue, reduce expenditure, save infrastructure costs, bring forward Production schedules), ASX require an updated prospectus and an EGM for the approval of the new deal, which includes Medcan, with BioHealth. Until the new paperwork is prepared the company is required to provide ongoing and updated Supplementary notices to inform the market as the changes occur.
The company would once again like to clarify the following:
(posted as requested by the Board of Cann Global)
RENTAL PROPERTY
Posts that indicate, question or assume that Cann Global, the Feldman's or AGMPL own the Bellevue Hill property are FALSE & MISLEADING!
PAYING RENT TO DIRECTORS OR ASSOCIATED COMPANIES
Posts that indicate, question or assume that Cann Global, the Feldman's, AGMPL or any of their associated companies double-dip or pay themselves back the rent are FALSE & MISLEADING!
AGMPL 1.
Posts that indicate, question or assume that AGMPL, the management company for Cann Global (formerly QBL) have anything to do with the Volcan debt are FALSE & MISLEADING!
AGMPL 2.
Posts that indicate, question or assume that the legally registered management company, AGMPL, that facilitates administration payments for the management of Cann Global Ltd (formerly QBL) are in any way, operating unprofessionally, or are in contravention to the Corporations Act, are FALSE & MISLEADING!
PAYMENTS TO DIRECTORS
Posts that indicate, question or assume that the Feldman's are paid in the highest category for MM Directors are
INCORRECT! As per the latest Quarterlies presented to the ASX by participating MM companies, Cann Global's administration/staff costs are in the bottom 35% of Public MM companies that have submitted Quarterlies. Please refer to the latest ASX platform Quarterlies for MM companies.
Thanks,
Neil1959
on behalf of the Board of Cann Global
hi Neil, thank you for those response. But I can’t believe you still need to answer those questions, as they have been answered many times. When are these few people are going to be held accountable.
Hopefully this the the end of these questions.
keep up the good work Neil.
